Back to Search Start Over

Influence of nocturnal hypoxemia on follow-up course after type B acute aortic syndrome

Authors :
Delsart, P. (Pascal)
Soquet, J. (Jerome)
Pierache, A. (Adeline)
Dedeken, M. (Maxime)
Fry, S. (Stephanie)
Mallart, A. (Anne)
Pontana, F. (Francois)
Azzaoui, R. (Richard)
Juthier, F. (Francis)
Sobocinski, J. (Jonathan)
Mounier Vehier, C. (Claire)
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U1011 (RNMCD)
Institut Pasteur de Lille
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL)
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS)
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 (RNMCD)
Institut Coeur Poumon [CHU Lille]
Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 (MBLC - ADDS)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS)
Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
Université de Lille
Inserm
CHU Lille
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires [RNMCD - U1011]
Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017
Récepteurs nucléaires, Maladies Cardiovasculaires et Diabète (EGID) - U1011
Advanced Drug Delivery Systems (ADDS) - U1008
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Source :
BMC Pulmonary Medicine, BMC Pulmonary Medicine, 2021, BMC Pulmonary Medicine, 21, pp.401. ⟨10.1186/s12890-021-01778-y⟩, BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-10 (2021)
Publication Year :
2021
Publisher :
HAL CCSD, 2021.

Abstract

Introduction Association between sleep nocturnal breathing disorders and acute aortic syndrome (AAS) has been described but mid-term data are scarce. Objectives We assessed the prognostic value of sleep apnea parameters and their relationship with aortic morphology after the onset of a type B AAS. Methods Between January 2010 and January 2018, sleep apnea screening in post type B AAS was prospectively performed. The association of sleep apnea parameters with aortic morphology and aortic expansion during follow-up was studied. Results Over the 8-year-study period, 103 patients were included, with a mean age of 57.8 ± 12.1 years old. Median follow-up was 25.0 months (11.0–51.0). Thirty-two patients (31%) required aortic stenting during the acute phase. In patients treated by aortic stenting, the descending thoracic aortic diameter was positively associated with a higher percentage of nocturnal time of saturation ≤ 90% after adjustment (p = 0.016). During follow-up, the nocturnal time of saturation ≤ 90% in patients treated by medical therapy was the only parameter associated with significant aortic expansion rate (r = 0.26, p = 0.04). Thirty-eight patients started and sustained nocturnal ventilation during follow-up. The association between aortic expansion rate and nocturnal time of saturation ≤ 90% did not persist during follow-up after adjustment on nocturnal ventilation initiation (r = 0.25, p = 0.056). Conclusions Nocturnal hypoxemia parameters are positively associated with the max onset aortic diameter and significant aortic growth after type B AAS. Nocturnal ventilation seems to mitigate aortic expansion during follow-up.

Details

Language :
English
ISSN :
14712466
Database :
OpenAIRE
Journal :
BMC Pulmonary Medicine, BMC Pulmonary Medicine, 2021, BMC Pulmonary Medicine, 21, pp.401. ⟨10.1186/s12890-021-01778-y⟩, BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-10 (2021)
Accession number :
edsair.doi.dedup.....439e2d8de75b201231647dcb86b6f378
Full Text :
https://doi.org/10.1186/s12890-021-01778-y⟩